NCT05846477

Brief Summary

This research project compares the clinical performance of the cortical bone trajectory CBT insertion technique with the current clinical Gold standard, the Pedicle screw insertion technique. Both techniques are performed by aid of MySpine patient-specific guide systems.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
44

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 4, 2021

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

April 25, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 6, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2024

Completed
Last Updated

May 6, 2023

Status Verified

May 1, 2023

Enrollment Period

3.1 years

First QC Date

April 25, 2023

Last Update Submit

May 4, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Spine surgical patient outcome changing in the time respect the preoperative

    Change in Core Outcome Measures Index (COMI) for the assessment of people affected by degenerative lumbar disease in daily practice

    baseline, 6 weeks, 3 months, 6 months, 12 months

Secondary Outcomes (4)

  • Spine Disability index

    baseline, 6 weeks, 3 months, 6 months, 12 months

  • Pain perception

    baseline, 6 weeks, 3 months, 6 months, 12 months

  • Bone fusion

    baseline, 12 months

  • Incidence of adverse event Device-related

    baseline, 6 weeks, 3 months, 6 months, 12 months

Study Arms (2)

MySpine MC

spinal stabilization via cortical bone trajectory with the support of patient specific guide (MySpine MC technology)

Device: MySpine

MySpine STD

spinal stabilization via standard pedicle screw positioning with the support of patient specific guide (MySpine std technology)

Device: MySpine

Interventions

MySpineDEVICE

patient specific guide for screw positioning

MySpine MCMySpine STD

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients listed for lumbar intervertebral body fusion meeting all inclusion/exclusion criteria, will be proposed to take part to the current comparative research project during their pre-operative visit (consecutive ongoing recruitment through project leader in daily clinical practice). They will be provided with an information letter and, in case of acceptance to participate to the research project, asked to sign a consent form in order to further use of personal and clinical data collected during standard practice visit. The patient will be assigned to the research project group according to two consecutive series (First serie: MySpine MC and second serie: MySpine STD).

You may qualify if:

  • patients affected by degenerative disc disease, osteochondrosis and grade I spondylolisthesis needing a one/two level surgical treatment with posterior approach and screw fixation
  • those who need a surgical procedure of lumbar spine stabilization from level L1 to level L5.
  • patients who are willing and able to provide written informed consent for participation in the study. Written informed consent must be obtained prior to the patient's surgery
  • Healthy patients or patients with mild or severe systemic disease identified as patients with ASA score 1, 2 or 3.
  • Patients with BMI ≤ 35 kg/m2
  • non responsive or insufficient response to conservative treatment.

You may not qualify if:

  • Patients presenting contraindications as defined by Medacta instruction for use
  • Patients affected by lytic spondylolisthesis and degenerative spondylolisthesis with grade≥2 will be excluded
  • Patients \<18 years
  • Patients who are pregnant or intend to become pregnant during the study
  • Known substance or alcohol abuse

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Schulthess Klinik

Zurich, Switzerland

RECRUITING

MeSH Terms

Conditions

Intervertebral Disc DegenerationOsteochondrosis

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal Diseases

Study Officials

  • François Porchet, Dr

    Schulthess Klinik

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Elisa Bonacina, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 25, 2023

First Posted

May 6, 2023

Study Start

February 4, 2021

Primary Completion

February 28, 2024

Study Completion

February 28, 2024

Last Updated

May 6, 2023

Record last verified: 2023-05

Locations